Clinical Trials on Other Iris and Ciliary Body Disorders

Total 11879 results

Cairo University

Completed

Evaluation of Topical Anesthesia Alone Versus Combined With Intracameral LIdocaine 1%

Other Iris and Ciliary Body Disorders

Saudi Arabia
Case Comprehensive Cancer Center

Completed

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Recurrent Intraocular Melanoma

United States
National Cancer Institute (NCI)

Completed

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder | Body Weight Change

United States, Brazil, United Kingdom
Alkermes, Inc.

Recruiting

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Schizophrenia | Bipolar I Disorder

United States, Argentina, Mexico, Brazil, Colombia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Liver Metastases | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Extraocular Extension Melanoma

United States
Washington University School of Medicine

Completed

Effects of Antipsychotic Medications on Energy Intake and Expenditure (DLW)

Schizophrenia | Schizoaffective Disorder | Weight Gain

United States
Eli Lilly and Company

Completed

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Schizophrenia | Schizoaffective Disorders

United States, Puerto Rico, Mexico, Brazil, Israel, Korea, Republic of, Russian Federation
Orexigen Therapeutics, Inc

Terminated

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States
Huiwu Xing

Completed

Prediction of Early Recovery of Liver Function After LDLT in Children: An Ambispective Cohort Study

Liver and Biliary Tract Disorders in Duration of Pregnancy | Other End-stage Liver Diseases in Children

China
Johann Wolfgang Goethe University Hospital

Completed

Comparison of the Guide-wire G-240 to a Combination of a Flexible/Hydrophil and a Nitinol Guide Wire

Other Specified Diseases of Biliary Tract

Germany
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Columbia...

Terminated

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia (MELT)

Overweight | Schizophrenia | Schizoaffective Disorder

United States
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Terminated

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Schizophrenia

United States, Argentina, Canada, Chile, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Lithuania, Peru, Slovakia, South Africa
Eli Lilly and Company

Completed

Weight Gain Management in Patients With Schizophrenia

Schizophrenia

Brazil
National Cancer Institute (NCI)

Completed

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension Melanoma

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIB Melanoma | Stage IIC Melanoma

United States
National Institute of Mental Health (NIMH)

Completed

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) (METS)

Schizophrenia

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Lifestyle Modification for Weight Loss in Schizophrenia

Obesity | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Schizophrenic Disorders

Korea, Republic of
National Cancer Institute (NCI)

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Recurrent Melanoma | Stage IV Melanoma | Uveal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension Melanoma

Canada, United States
National Cancer Institute (NCI)

Completed

Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye

Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension Melanoma

United States
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Fundació Sant Joan de Déu
Parc Sanitari Sant Joan de Déu; Hospital del Mar; Hospitales Universitarios Virgen... and other collaborators

Not yet recruiting

Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf) (MCTf)

Psychosis | Mother-Child Relations
National Cancer Institute (NCI)

Completed

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Intraocular Melanoma | Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Extraocular Extension Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Superficial... and other conditions

Canada
Centre for Addiction and Mental Health

Completed

An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic Illness

Psychotic Illnesses

Canada
Johns Hopkins University
National Institute of Mental Health (NIMH); University of Maryland; University... and other collaborators

Completed

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (IMPACT)

Psychotic Disorders

United States
Corcept Therapeutics

Completed

This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications.

Antipsychotic-induced Weight Gain (AIWG)

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Naltrexone for Antipsychotic-Induced Weight Gain (NTX)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Severe Major Depression With Psychotic Features

United States
National Yang Ming University

Completed

Effectiveness of a Nurse Facilitated Face Care Group in Patients With Schizophrenia

Body Image

Taiwan
Alkermes, Inc.

Completed

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Schizophrenia | Bipolar I Disorder | Schizophreniform Disorders

United States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
Medical University of South Carolina
Eli Lilly and Company

Withdrawn

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

Schizophrenia | Bipolar Disorder

United States
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia

Obesity | Schizophrenia

Brazil
Eli Lilly and Company

Completed

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
US Department of Veterans Affairs
University of California, Los Angeles; asd

Completed

Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)

Schizoaffective Disorder | Weight Gain | Chronic Illness | Schizophrenia Disorders

United States
Yale University

Completed

An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia (ALA)

Obesity | Schizophrenia | Weight Loss

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Active, not recruiting

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage IIIC Intraocular Melanoma | Stage I Intraocular Melanoma | Stage IIA Intraocular Melanoma | Stage IIB Intraocular... and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditions

United States
University of Texas Southwestern Medical Center
Amylin Pharmaceuticals, LLC.

Completed

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Diabetes | Schizophrenia | Schizoaffective Disorder | Weight Gain

United States
Nathan Kline Institute for Psychiatric Research
Stanley Medical Research Institute

Completed

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Autism Spectrum Disorder | Bipolar I Disorder | Psychotic Disorder Not Otherwise Specified | Bipolar II | Bipolar NOS(Not Otherwise Specified)

United States
Central South University

Completed

A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

China
Illinois Institute of Technology
National Institute on Minority Health and Health Disparities (NIMHD); ACCESS... and other collaborators

Completed

Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness

Obesity | Mental Disorder

United States
VA Office of Research and Development
National Institute of Mental Health (NIMH); University of California, Los Angeles

Completed

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) (EQUIP-2)

Schizophrenia | Weight Gain | Chronic Illness | Psychotic Disorder

United States
Edgard Costa de Vilhena
Amparo Maternal Maternidade Social

Completed

Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder

Overweight | Pregnancy | Mental Disorder

Brazil
Corcept Therapeutics

Completed

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Antipsychotic-induced Weight Gain (AIWG)

United States
University Medicine Greifswald

Completed

Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions (NUPAN)

Pancreatic Cancer | Weight Loss | Biliary Tract Cancer
Yale University
Ethel F. Donaghue Women's Health Investigator Program at Yale

Completed

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Obesity | Schizophrenia | Schizoaffective Disorder

United States
New York State Psychiatric Institute
Temple University; The Zucker Hillside Hospital; Feinstein Institutes for Medical...

Not yet recruiting

Shared Decision Making for Antipsychotic Medications

Schizophrenia | Schizoaffective Disorder | Delusional Disorder | Schizophreniform Disorders | Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
Nathan Kline Institute for Psychiatric Research

Terminated

Metformin for Weight Loss in Schizophrenia

Obesity | Schizophrenia

United States
TsaoTun Psychiatric Center, Department of Health...

Unknown

The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia

Obesity | Schizophrenia

Taiwan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (CRESSOB)

Schizophrenia

Clinical Trials on Other Iris and Ciliary Body Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations